Literature DB >> 27013135

Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications.

Kristof Zarschler1, Louise Rocks2, Nadia Licciardello3, Luca Boselli2, Ester Polo2, Karina Pombo Garcia4, Luisa De Cola5, Holger Stephan4, Kenneth A Dawson2.   

Abstract

Ultrasmall nanoparticulate materials with core sizes in the 1-3nm range bridge the gap between single molecules and classical, larger-sized nanomaterials, not only in terms of spatial dimension, but also as regards physicochemical and pharmacokinetic properties. Due to these unique properties, ultrasmall nanoparticles appear to be promising materials for nanomedicinal applications. This review overviews the different synthetic methods of inorganic ultrasmall nanoparticles as well as their properties, characterization, surface modification and toxicity. We moreover summarize the current state of knowledge regarding pharmacokinetics, biodistribution and targeting of nanoscale materials. Aside from addressing the issue of biomolecular corona formation and elaborating on the interactions of ultrasmall nanoparticles with individual cells, we discuss the potential diagnostic, therapeutic and theranostic applications of ultrasmall nanoparticles in the emerging field of nanomedicine in the final part of this review.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Active targeting; Cancer; Nanomedicine; Pharmacokinetics; Protein corona; Renal excretion; Ultrasmall nanoparticles

Mesh:

Year:  2016        PMID: 27013135     DOI: 10.1016/j.nano.2016.02.019

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  37 in total

1.  Ultrasmall silica nanoparticles directly ligate the T cell receptor complex.

Authors:  Bradley Vis; Rachel E Hewitt; Tom P Monie; Camilla Fairbairn; Suzanne D Turner; Stephen D Kinrade; Jonathan J Powell
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

Review 2.  Nanotechnology based therapeutic application in cancer diagnosis and therapy.

Authors:  Ragini Singh
Journal:  3 Biotech       Date:  2019-10-23       Impact factor: 2.406

Review 3.  Redox-active nanomaterials for nanomedicine applications.

Authors:  Christopher M Sims; Shannon K Hanna; Daniel A Heller; Christopher P Horoszko; Monique E Johnson; Antonio R Montoro Bustos; Vytas Reipa; Kathryn R Riley; Bryant C Nelson
Journal:  Nanoscale       Date:  2017-10-19       Impact factor: 7.790

Review 4.  Nanomedicines for renal disease: current status and future applications.

Authors:  Nazila Kamaly; John C He; Dennis A Ausiello; Omid C Farokhzad
Journal:  Nat Rev Nephrol       Date:  2016-10-31       Impact factor: 28.314

5.  Simultaneous Enhancement of Photoluminescence, MRI Relaxivity, and CT Contrast by Tuning the Interfacial Layer of Lanthanide Heteroepitaxial Nanoparticles.

Authors:  Sha He; Noah J J Johnson; Viet Anh Nguyen Huu; Esther Cory; Yuran Huang; Robert L Sah; Jesse V Jokerst; Adah Almutairi
Journal:  Nano Lett       Date:  2017-07-07       Impact factor: 11.189

6.  Development of europium doped core-shell silica cobalt ferrite functionalized nanoparticles for magnetic resonance imaging.

Authors:  Bhavesh D Kevadiya; Aditya N Bade; Christopher Woldstad; Benson J Edagwa; JoEllyn M McMillan; Balasrinivasa R Sajja; Michael D Boska; Howard E Gendelman
Journal:  Acta Biomater       Date:  2016-12-01       Impact factor: 8.947

7.  Binding kinetics of ultrasmall gold nanoparticles with proteins.

Authors:  André L Lira; Rodrigo S Ferreira; Ricardo J S Torquato; Huaying Zhao; Maria Luiza V Oliva; Sergio A Hassan; Peter Schuck; Alioscka A Sousa
Journal:  Nanoscale       Date:  2018-02-15       Impact factor: 7.790

8.  Functionalized Scintillating Nanotubes for Simultaneous Radio- and Photodynamic Therapy of Cancer.

Authors:  Irene Villa; Chiara Villa; Roberta Crapanzano; Valeria Secchi; Massimo Tawfilas; Elena Trombetta; Laura Porretti; Andrea Brambilla; Marcello Campione; Yvan Torrente; Anna Vedda; Angelo Monguzzi
Journal:  ACS Appl Mater Interfaces       Date:  2021-03-15       Impact factor: 9.229

9.  Targeting the Surface of the Protein 14-3-3 by Ultrasmall (1.5 nm) Gold Nanoparticles Carrying the Specific Peptide CRaf.

Authors:  Tatjana Ruks; Kateryna Loza; Marc Heggen; Christian Ottmann; Peter Bayer; Christine Beuck; Matthias Epple
Journal:  Chembiochem       Date:  2021-01-28       Impact factor: 3.164

Review 10.  Biomolecular interactions of ultrasmall metallic nanoparticles and nanoclusters.

Authors:  Alioscka A Sousa; Peter Schuck; Sergio A Hassan
Journal:  Nanoscale Adv       Date:  2021-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.